Device Trial Radar · NCT04024943
Personalized Therapy Study - Attain Stability Quad Post-Approval Study
Last checked: Nov 20, 2026Latest source record: Feb 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,092
Actual
Start
Aug 21, 2017
Primary completion
Jul 2027
Study completion Jan 2028
Sponsor
- Lead sponsor
- MedtronicPublic (MDT)
- Sponsor type
- Industry
- First posted
- Jul 18, 2019
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this Post-Approval Study (PAS) is to evaluate the long-term performance of the Model 4798 Left Ventricular (LV) lead in a real-world patient population. Patients will be followed for the duration of the PAS. This study is required by FDA as a condition of approval of the Model 4798 LV lead and is integrated within the Product Surveillance Registry (PSR).
Conditions
- Heart Failure
Interventions
Quadripolar LV LeadDevice
The Attain Stability Quad MRI SureScan LV Lead (Model 4798) is an active fixation quadripolar LV lead based on the Attain Performa lead family models (4298, 4398, and 4598). The lead incorporates an active fixation helix similar to the OUS commercialized Attain Stability bipolar LV lead (Model 20066/4796) which is designed to allow an implanter more options in lead location.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of patients without a lead- related event at 5 years post-implantTime frame: 5 years
Locations
115 sites in 9 countries. Site status is shown where the registry gives one.
Alaska Heart
Anchorage, Alaska
Southwest EP
Chandler, Arizona
Cardiology Associates of Northeast Arkansas
Jonesboro, Arkansas
112 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.